Particle-cell dynamics in human blood flow: implications for vascular-targeted drug delivery.
about
Drug carrier interaction with blood: a critical aspect for high-efficient vascular-targeted drug delivery systemsParticle margination and its implications on intravenous anticancer drug deliveryVascular targeting of nanocarriers: perplexing aspects of the seemingly straightforward paradigmStenosis triggers spread of helical Pseudomonas biofilms in cylindrical flow systems.Plasma protein corona modulates the vascular wall interaction of drug carriers in a material and donor specific mannerThe influence of blood on targeted microbubblesShaping cancer nanomedicine: the effect of particle shape on the in vivo journey of nanoparticlesEffect of variation in hemorheology between human and animal blood on the binding efficacy of vascular-targeted carriers.Differential Impact of Plasma Proteins on the Adhesion Efficiency of Vascular-Targeted Carriers (VTCs) in Blood of Common Laboratory AnimalsBarriers to drug delivery in solid tumors.Nanodiagnostics, nanopharmacology and nanotoxicology of platelet-vessel wall interactions.Role of particle size, shape, and stiffness in design of intravascular drug delivery systems: insights from computations, experiments, and nature.The effects of particle size, shape, density and flow characteristics on particle margination to vascular walls in cardiovascular diseases.Flow shear stress differentially regulates endothelial uptake of nanocarriers targeted to distinct epitopes of PECAM-1.Inductive heating kills cells that contribute to plaque: a proof-of-concept.Effects of shear rate, confinement, and particle parameters on margination in blood flow.Exploring deformable particles in vascular-targeted drug delivery: Softer is only sometimes better.Evaluation of Receptor-Ligand Mechanisms of Dual-Targeted Particles to an Inflamed Endothelium.
P2860
Q26798467-75EFEC24-9F5B-43A8-AF97-E54FF50B6CB9Q26829530-A5B71056-AF10-404B-A782-21119D6AC353Q27026630-E1B3AD97-05C7-49A6-9A6D-88673CB55D8FQ27347627-EBE17492-D607-41B9-8C8E-413441B4182FQ28543040-AFA018A3-0BC9-4461-A235-B945B34FCCECQ30399305-588BBEE4-C458-4CE8-BC10-00B408E6095AQ33755231-BA0D7B16-0270-43F2-8D13-0BB01DE88E76Q35784267-47473A87-9B74-431C-82A8-CE9898B6C4DEQ36900233-320BE449-3290-4B3C-BA12-119A37941D20Q38234567-30662968-C402-4CE7-BCE9-ECC1B5D0AF89Q38495085-61B3007B-C099-45F7-9CE8-97E6AE183288Q38573793-392BFF43-4E84-4657-BA07-DB8698F25537Q38847912-59F50084-B4F0-48EE-92F3-BCA00FD25EE2Q38875899-0FA4173F-0E14-4F46-A93F-66197FA64B84Q40260089-816AE40C-4CA7-45E9-AEF6-7095E5F967A6Q50248397-95921841-3F91-48DF-88DD-79C14B10DF7DQ51000739-04B6812A-2A3A-4659-94F4-0B0254A87411Q51055092-5C1AE838-A64A-414D-A0C8-47EA3839B74A
P2860
Particle-cell dynamics in human blood flow: implications for vascular-targeted drug delivery.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Particle-cell dynamics in huma ...... scular-targeted drug delivery.
@en
Particle-cell dynamics in huma ...... scular-targeted drug delivery.
@nl
type
label
Particle-cell dynamics in huma ...... scular-targeted drug delivery.
@en
Particle-cell dynamics in huma ...... scular-targeted drug delivery.
@nl
prefLabel
Particle-cell dynamics in huma ...... scular-targeted drug delivery.
@en
Particle-cell dynamics in huma ...... scular-targeted drug delivery.
@nl
P1476
Particle-cell dynamics in huma ...... ascular-targeted drug delivery
@en
P2093
Mariana Carrasco-Teja
Peter J Onyskiw
P304
P356
10.1016/J.JBIOMECH.2012.08.035
P577
2012-09-23T00:00:00Z